Search
for
Sort by
Research 61–90 of 1000+
- Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study
- Which is the ideal JAK inhibitor for alopecia areata – Baricitinib, tofacitinib, ritlecitinib or ifidancitinib - Revisiting the immunomechanisms of the JAK pathway
- Real-world assessment of ritlecitinib in patients with severe alopecia areata: a 24-week multicentre retrospective study
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Low-dose tofacitinib for treating patients with severe alopecia areata: an efficient and cost-saving regimen
- Upadacitinib for management of alopecia areata and rheumatoid arthritis: Letter to the editor
- Functional Interpretation of Genome-Wide Association Study Evidence in Alopecia Areata
- FDA approval of Deuruxolitinib: A New Treatment Option for Severe Alopecia Areata
- Upadacitinib for Severe Alopecia Areata in Adults and Adolescents
- Advances in the mechanism and new therapies of alopecia areata
- When hair dig into the brain, JAKi , may help!
- Alopecia Areata and Systemic Lupus Erythematosus: Insights From a Nationwide Case–Control Study
- Novel investigational drugs for alopecia areata and future perspectives
- Peripheral neuropathy associated with tofacitinib use in alopecia universalis
- Tofacitinib for the Treatment of Severe Alopecia Areata in Adults and Adolescents
- A Novel Hope for Alopecia Totalis Patients: Case Report
- Dissecting Cellulitis of the Scalp Successfully Treated with a Combination of Ixekizumab and Tofacitinib
- Tofacitinib for the treatment of lichen planopilaris: A case series
- Alopecia areata and tofacitinib: a prospective multicenter study from a Saudi population
- Topical tofacitinib for the treatment of alopecia areata affecting facial hair
- Alopecia – New building blocks
- Alopecia Areata in Skin of Color Patients: New Considerations Sparked by the Approval of Baricitinib
- 33774 Baricitinib results in eyebrow and eyelash growth in patients with alopecia areata who do not achieve 20% or less scalp hair loss
- Annual Convention in the Time of COVID
- Tratamento adjuvante com minoxidil oral para tratamento de alopecia areata refratária a inibidores de JAK
- Alopecia Areata: Current and Emerging Therapies
- Case Report: Vitiligo and Alopecia Universalis Following Rituximab Therapy in a Patient with Myasthenia Gravis
- Evidence for the off-label use of tofacitinib in alopecia areata
- Pattern hair loss distribution: a novel presentation for alopecia areata
- EE325 Budget Impact of Baricitinib for Patients with Severe Alopecia Areata